2012 Conditions Events Sleep 
The Cannigma
JANUARY 3, 2023
A 2016 study examined endocannabinoid levels in women with and without endometriosis, a condition that causes painful periods due to growth on the outside of the uterus. Researchers concluded, “the ECS is intimately involved in the central and local control of female reproductive events.”. Beta-Caryophyllene.
TheAnswerPage
JANUARY 11, 2022
Since 2012, TheAnswerPage.com has addressed the immense need for unbiased evidence-based high quality education focused on the endocannabinoid system and medical marijuana. Results of an observational study merely suggest an association between a therapeutic agent or an event and an outcome.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
MAY 22, 2021
Due to it’s high temporal value, EEG shines at detecting epilepsy, sleep disorders, dementia and any other structural brain disease or disorder. This means scientists can witness the precise sequence of cognitive events as they occur in the brain instead of a nebulous cloud of brain activity. Carhart-Harris et al.2012):
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. years (Atakan 2012 ). Published by The Journal of Cannabis Research. Background.
Cannabis Law Report
SEPTEMBER 23, 2019
27 There is moderate evidence for the use of cannabinoids for sleep and limited evidence for use in psychiatric conditions, such as post-traumatic stress disorder, depression, anxiety, and psychosis; appetite stimulation and weight gain; and no evidence for cancer treatment. Moderate evidence exists for the use of cannabis for sleep.
Green Relief
MAY 13, 2018
These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. In 2012, the Journal of Neuropsychiatric Research reported that CB2 receptor activation attenuates blood-brain barrier damage in a rodent model of TBI.
Green Relief
MAY 12, 2018
These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. In 2012, the Journal of Neuropsychiatric Research reported that CB2 receptor activation attenuates blood-brain barrier damage in a rodent model of TBI.
Expert insights. Personalized for you.
106 
Let's personalize your content